| Studies | Patients | Pooled effect size (CI) | P-value | I2(%) |
---|---|---|---|---|---|
Physiotherapy exercise compared with minimal intervention | |||||
Physical function | |||||
3-4 months follow up | 3 | 254 | −0.37 [−0.62, −0.12] | 0.004 | 0% |
6 month follow up | 3 | 260 | −0.43 [−0.95, 0.08] | 0.10 | 76% |
12 month follow up | 4 | 397 | −0.21 [−0.70, 0.29] | 0.42 | 83% |
Physical function in studies with low risk of bias | |||||
3-4 months follow up | 2 | 119 | −0.35 [−0.62, −0.08] | 0.01 | 0% |
6 month follow up | 2 | 185 | −0.64 [−1.15, −0.13] | 0.01 | 65% |
12 month follow up | 2 | 253 | −0.37 [−1.36, 0.61] | 0.46 | 93% |
Pain | |||||
3-4 months follow up | 2 | 103 | −0.45 [−0.85, −0.06] | 0.02 | 0% |
6 month follow up | 4 | 287 | −0.29 [−0.68, 0.10] | 0.15 | 60% |
12 month follow up | 4 | 281 | −0.15 [−0.64, 0.35] | 0.57 | 75% |
Pain in studies with low risk of bias | |||||
3-4 months follow up | 1 | 27 | −0.27 [−1.05, 0.50] | 0.49 |  |
6 month follow up | 2 | 185 | −0.58 [−0.88, −0.29] | 0.0001 | 0% |
12 month follow up | 1 | 110 | −0.73 [−1.12, −0.35] | 0.0002 |  |
Range of motion extension | |||||
3-4 months follow up | 2 | 178 | −4.14 [−7.10, 1.18] | 0.006 | 82% |
6 month follow up | 1 | 74 | 0.00 [−1.37, 1.37] | 1.00 |  |
12 month follow up | 2 | 217 | 0.42 [−0.54, 1.38] | 0.39 | 0% |
Range of motion extension in studies with low risk of bias | |||||
3-4 months follow up | 1 | 143 | −2.60 [−4.48, −0.72] | 0.007 |  |
6Â month follow up | 0 | Â | Â | Â | Â |
12 month follow up | 1 | 143 | 0.20 [−0.92, 1.32] | 0.73 |  |
Range of motion flexion | |||||
3-4 months follow up | 4 | 321 | −5.23 [−11.16, 0.70] | 0.08 | 83% |
6 month follow up | 3 | 217 | −4.06 [−6.67, −1.46] | 0.02 | 0% |
12 month follow up | 4 | 360 | −2.21 [−4.31, −0.10] | 0.04 | 0% |
Range of motion flexion in studies with low risk of bias | |||||
3-4 months follow up | 1 | 116 | −2.00 [−4.78, 0.78] | 0.16 |  |
6 month follow up | 1 | 116 | −5.00 [−8.14, −1.86] | 0.002 |  |
12 month follow up | 2 | 259 | −2.38 [−4.80, 0.05] | 0.05 | 0% |
Walking | Â | Â | Â | Â | Â |
Longest follow up (all 12 months) | 3 | 169 | −0.17 [−0.48, 0.13] | 0.27 | 0% |
Home-based compared with outpatient delivery of physiotherapy exercise | |||||
Physical function | |||||
3-4 months follow up | 4 | 310 | −0.03 [−0.25, 0.19] | 0.80 | 0% |
6 month follow up | 2 | 150 | 0.05 [−0.27, 0.38] | 0.74 | 0% |
12 month follow up | 2 | 214 | 0.11 [−0.16, 0.38] | 0.42 | 0% |
Physical function in studies with low risk of bias | |||||
3-4 months follow up | 2 | 199 | −0.15 [−0.43, 0.13] | 0.29 | 0% |
6 month follow up | 1 | 82 | 0.18 [−0.25, 0.62] | 0.41 |  |
12 month follow up | 1 | 87 | 0.01 [−0.41, 0.44] | 0.95 |  |
Pain | |||||
3-4 months follow up | 3 | 248 | −0.00 [−0.25, 0.25] | 0.98 | 0% |
6 month follow up | 1 | 85 | −0.05 [−0.48, 0.38] | 0.82 |  |
12 month follow up | 1 | 92 | −0.13 [−0.53, 0.28] | 0.55 |  |
Pain in studies with low risk of bias | |||||
3-4 months follow up | 2 | 207 | −0.07 [−0.35, 0.20] | 0.59 | 0% |
6 month follow up | 1 | 85 | −0.05 [−0.48, 0.38] | 0.82 |  |
12 month follow up | 1 | 92 | −0.13 [−0.53, 0.28] | 0.55 |  |
Range of motion extension | |||||
3-4 months follow up | 3 | 261 | −0.21 [−0.46, 0.05] | 0.11 | 6% |
6Â month follow up | 0 | Â | Â | Â | Â |
12 month follow up | 1 | 83 | −0.18 [−0.61, 0.25] | 0.41 |  |
Range of motion extension in studies with low risk of bias | |||||
3-4 months follow up | 3 | 261 | −0.21 [−0.46, 0.05] | 0.11 | 6% |
6Â month follow up | 0 | Â | Â | Â | Â |
12 month follow up | 1 | 83 | −0.18 [−0.61, 0.25] | 0.41 |  |
Range of motion flexion | |||||
3-4 months follow up | 3 | 329 | −0.22 [−0.44, −0.01] | 0.04 | 0% |
6 month follow up | 1 | 68 | −0.18 [−0.65, 0.30] | 0.47 |  |
12 month follow up | 2 | 202 | 0.07 [−0.21, 0.35] | 0.61 | 0% |
Range of motion flexion in studies with low risk of bias | |||||
3-4 months follow up | 3 | 329 | −0.22 [−0.44, −0.01] | 0.04 | 0% |
6 month follow up | 1 | 68 | −0.18 [−0.65, 0.30] | 0.47 |  |
12 month follow up | 1 | 83 | −0.05 [−0.48, 0.38] | 0.81 |  |
Walking | Â | Â | Â | Â | Â |
Longest follow up (2 studies 12 months, 1 study 6 months) | 3 | 267 | −0.02 [−0.26, 0.22] | 0.87 | 37% |